Clostridium difficile infection (CDI) is increasingly common among patients with inflammatory bowel disease (IBD) and is linked to worse outcomes in these patients.
A study conducted at King Abdulaziz Medical City analyzed data from 89 CDI patients, focusing on demographics and various health correlations over a four-year period.
Results showed that most CDI patients were adults, primarily males, with a high prevalence among immunocompromised individuals, especially those with cancer; the main diagnostic method used was PCR.